Pasar al contenido principal

IDENTIFICACION Y CARACTERIZACION DE LOS DETERMINANTES DE ESPECIFICADAD DE TEJIDO EN PATOLOGIAS CON DEFECTOS DE LA TRADUCCION MITOCONDRIAL

PID2020-116970GA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification and characterization of a new pathologic mutation in a large Leber hereditary optic neuropathy pedigree

  • Emperador, Sonia
  • Habbane, Mouna
  • López-Gallardo, Ester
  • Del Rio, Alejandro
  • Llobet, Laura
  • Mateo, Javier
  • Sanz-López, Ana María
  • Fernández-García, María José
  • Sánchez-Tocino, Hortensia
  • Benbunan-Ferreiro, Sol
  • Calabuig-Goena, María
  • Narvaez-Palazón, Carlos
  • Fernández-Vega, Beatriz
  • González-Iglesias, Héctor
  • Urreizti, Roser
  • Artuch, Rafael
  • Pacheu-Grau, David
  • Bayona-Bafaluy, Pilar
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
Most patients suffering from Leber hereditary optic neuropathy carry one of the three classic pathologic mutations, but not all individuals with these genetic alterations develop the disease. There are different risk factors that modify the penetrance of these mutations. The remaining patients carry one of a set of very rare genetic variants and, it appears that, some of the risk factors that modify the penetrance of the classical pathologic mutations may also affect the phenotype of these other rare mutations., This work was supported by grants from Instituto de Salud Carlos III [FIS-PI20/00340 and FIS-PI21/00229] and European Regional Development Fund (FEDER); Ministerio de Ciencia e Innovación [PID2020-116970GA-I00 and RYC2020-029544-I funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and by “ESF Investing in your future”]; Gobierno de Aragón [LMP22_21; Grupos Consolidados B33_23R]; Fundación Mutua Madrileña [MMA]; and Precipita-FECYT crowfunding program [PR194]. CIBERER is an initiative of the ISCIII., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Toxic and nutritional factors trigger Leber hereditary optic neuropathy due to a mitochondrial tRNA mutation

  • Vela-Sebastián, Ana
  • López-Gallardo, Ester
  • Emperador, Sonia
  • Hernández-Ainsa, Carmen
  • Pacheu-Grau, David
  • Blanco, Ignacio
  • Ros, Andrea
  • Pascual-Benito, Ester
  • Rabaneda-Lombarte, Neus
  • Presas-Rodríguez, Silvia
  • García-Robles, Pilar
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
Leber hereditary optic neuropathy is a mitochondrial disease mainly due to pathologic mutations in mitochondrial genes related to the respiratory complex I of the oxidative phosphorylation system. Genetic, physiological, and environmental factors modulate the penetrance of these mutations. We report two patients suffering from this disease and harboring a m.15950G > A mutation in the mitochondrial DNA-encoded gene for the threonine transfer RNA. We also provide evidences supporting the pathogenicity of this mutation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Mitochondrial genetic background may impact statins side effects and atherosclerosis development in familial hypercholesterolemia

  • Ruiz Pesini, Eduardo
  • Bayona Bafaluy, María Pilar
  • Sanclemente, Teresa
  • Puzo, José
  • Montoya, Julio
  • Pacheu Grau, David
Heredity of familial hypercholesterolemia (FH) can present as a dominant monogenic disorder of polygenic origin or with no known genetic cause. In addition, the variability of the symptoms among individuals or within the same families evidence the potential contribution of additional factors than monogenic mutations that could modulate the development and severity of the disease. In addition, statins, the lipid-lowering drugs which constitute the first-line therapy for the disease, cause associated muscular symptoms in a certain number of individuals. Here, we analyze the evidence of the mitochondrial genetic variation with a special emphasis on the role of CoQ10 to explain this variability found in both disease symptoms and statins side effects. We propose to use mtDNA variants and copy numbers as markers for the cardiovascular disease development of FH patients and to predict potential statin secondary effects and explore new mechanisms to identify new markers of disease or implement personalized medicine strategies for FH therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A microscopy-based screen identifies cellular kinases modulating mitochondrial translation

  • Yousefi, Roya
  • Cruz-Zaragoza, Luis Daniel
  • Valpadashi, Anusha
  • Hansohn, Carina
  • Dahal, Drishan
  • Richter-Dennerlein, Ricarda
  • Rizzoli, Silvio
  • Urlaub, Henning
  • Rehling, Peter
  • Pacheu-Grau, David
Mitochondrial DNA encodes 13 subunits of the oxidative phosphorylation (OXPHOS) system, which are synthesized inside the organelle and essential for cellular energy supply. How mitochondrial gene expression is regulated and integrated into cellular physiology is little understood. Here, we perform a high-throughput screen combining fluorescent labeling of mitochondrial translation products with small interfering RNA (siRNA)-mediated knockdown to identify cellular kinases regulating translation. As proof of principle, the screen identifies known kinases that affect mitochondrial translation, and it also reveals several kinases not yet linked to this process. Among the latter, we focus on the primarily cytosolic kinase, fructosamine 3 kinase (FN3K), which localizes partially to the mitochondria to support translation. FN3K interacts with the mitochondrial ribosome and modulates its assembly, thereby affecting translation. Overall, our work provides a reliable approach to identify protein functions for mitochondrial gene expression in a high-throughput manner.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

ISR pathway contribution to tissue specificity of mitochondrial diseases

  • Vela-Sebastián, Ana
  • Bayona-Bafaluy, Pilar
  • Pacheu-Grau, David
Mitochondrial genetic defects caused by whole-body mutations typically affect different tissues in different ways. Elucidating the molecular determinants that cause certain cell types to be primarily affected has become a critical research target within the field. We propose a differential activation of the integrated stress response as a potential contributor to this tissue specificity.